ClearPoint Neuro, Inc.

NasdaqCM:CLPT Voorraadrapport

Marktkapitalisatie: US$355.7m

ClearPoint Neuro Inkomsten in het verleden

Verleden criteriumcontroles 0/6

De winst van ClearPoint Neuro is gedaald met een gemiddeld jaarlijks percentage van -29.4%, terwijl de winst van de Medical Equipment -industrie jaarlijks groeide met 12.9%. De inkomsten zijn groeide met een gemiddeld percentage van 20.3% per jaar.

Belangrijke informatie

-29.4%

Groei van de winst

-16.0%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie8.9%
Inkomstengroei20.3%
Rendement op eigen vermogen-56.0%
Nettomarge-64.1%
Volgende winstupdate07 Nov 2024

Recente prestatie-updates uit het verleden

Recent updates

Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 28%

Sep 14
Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 28%

Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load?

Aug 16
Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load?

Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 26%

Jul 11
Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 26%

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 09
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

ClearPoint Neuro: Macro-Induced Multiple Compression

Apr 25

Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?

Apr 19
Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?

Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report

Mar 15
Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report

Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?

Jan 04
Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?

Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Dec 06
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?

Nov 06
Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?

Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

Aug 18
Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump

Apr 17
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump

Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Jan 03
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

ClearPoint Neuro: Continuous Great Execution

Sep 19

ClearPoint Neuro: Picks & Shovels Galore

Aug 19

ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

Aug 18
ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

ClearPoint Neuro:  A 'Picks And Shovels' Biotech Company

Jul 25

ClearPoint Neuro: Continuous Execution Despite Covid Headwind

May 20

Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

Apr 25
Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides

Mar 18

Opbrengsten en kosten

Hoe ClearPoint Neuro geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NasdaqCM:CLPT Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 2428-182511
31 Mar 2426-212511
31 Dec 2324-222412
30 Sep 2322-222312
30 Jun 2322-212212
31 Mar 2321-182111
31 Dec 2221-161911
30 Sep 2220-161811
30 Jun 2219-161811
31 Mar 2217-161611
31 Dec 2116-14159
30 Sep 2116-12148
30 Jun 2115-9137
31 Mar 2114-7115
31 Dec 2013-7115
30 Sep 2012-7104
30 Jun 2012-6103
31 Mar 2012-6103
31 Dec 1911-693
30 Sep 1910-583
30 Jun 199-582
31 Mar 198-682
31 Dec 187-682
30 Sep 187-782
30 Jun 187-782
31 Mar 187-783
31 Dec 177-783
30 Sep 177-783
30 Jun 177-883
31 Mar 176-883
31 Dec 166-883
30 Sep 166-883
30 Jun 165-582
31 Mar 165-782
31 Dec 155-882
30 Sep 154-992
30 Jun 153-1393
31 Mar 154-1193
31 Dec 144-583
30 Sep 144-483
30 Jun 144-473
31 Mar 143-473
31 Dec 134-773

Kwaliteitswinsten: CLPT is momenteel verliesgevend.

Groeiende winstmarge: CLPT is momenteel verliesgevend.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: CLPT is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 29.4% per jaar.

Versnelling van de groei: Het is niet mogelijk om de winstgroei van CLPT over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.

Winst versus industrie: CLPT is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Medical Equipment industrie ( 11.7% ).


Rendement op eigen vermogen

Hoge ROE: CLPT heeft een negatief Return on Equity ( -55.96% ), omdat het momenteel verliesgevend is.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden